Genitourinary Cancer
News
Gut bacteria may fuel prostate cancer treatment resistance
The findings may suggest new therapeutic targets: the microbes living in the gut.
Conference Coverage
Many patients, doctors unaware of advancements in cancer care
“These patients must be spared the traumatic effects of being handed a death sentence that no longer reflects the current reality,” said Dr....
Conference Coverage
Most community-based oncologists skip biomarker testing
Survey shows that 48% of community clinicians use biomarker testing to guide treatment decisions, compared with 73% of academic clinicians.
News
Immunotherapy for cancer patients with poor PS needs a rethink
Patients should not receive immunotherapy just to reduce risk of side effects, doctor says.
News
Old saying about prostate cancer not true when it’s metastatic
“Most patients with metastatic prostate cancer die from it, rather than other possible causes of death,” researcher says.
News
‘Dawn of a new era’ in the treatment of renal cell carcinoma
Monotherapy with pembrolizumab was associated with significantly longer disease-free survival after nephrectomy than placebo in a trial of 994...
Conference Coverage
Although inconclusive, CV safety study of cancer therapy attracts attention
Even though PRONOUNCE, a trial comparing prostate cancer drugs for cardiovascular safety couldn’t reach a conclusion, it may prove to be a model...
News
‘Routine’ use of focal therapy for prostate cancer in next 5 years
Focal therapy rejects one-size-fits-all medicine in favor of individualized treatment.
News
One in three cancer articles on social media has wrong info
Physician says misleading information online may be harmful to patients.
News
Bone drugs for prostate cancer may result in survival benefit
Retrospective study shows the addition of bone resorption inhibitors to abiraterone, plus prednisolone, may lengthen survival.
